Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brecanavir/ritonavir vs Standard of Care in PI-Experienced HIV-1
NCT00242879Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- Aug 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of brecanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Aug 2005; status: terminated.
02
Drugs
brecanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00242879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242879.